ShareHoldingPatternnew - Accretion Pharmaceuticals Ltd.
Search Company
You can view Income Statement for the last 5 years.
ISIN No INE748C01038 52Wk High (Rs.) 26 BV (Rs.) 17.67 FV (Rs.) 10.00
Bookclosure 26/09/2025 52Wk Low (Rs.) 13 EPS (Rs.) 1.22 P/E (X) 14.18
Mkt Cap. (Rs. Cr.) 359.42 P/BV (X) 0.98 Div Yield (%) 0.00 Mkt Lot 1
Standalone Consolidated
(Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22
Months12121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARAR
FaceValue10.0010.0010.0010.00
     
     
INCOME    
Revenue From Operations [Net]312.63357.33262.77200.97
Other Operating Revenues51.990.0013.4711.07
Total Operating Revenues364.62357.33276.24212.04
     
Other Income69.4361.18114.9657.06
Total Revenue434.05418.51391.20269.10
     
EXPENSES    
Operating And Direct Expenses126.50158.16121.1572.89
Employee Benefit Expenses195.70186.09148.36105.19
Finance Costs6.678.729.0011.33
Depreciation And Amortisation Expenses24.3924.8221.2012.69
Other Expenses33.54434.7553.7237.77
Total Expenses386.80812.54353.43239.87
     
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax47.25-394.0337.7729.23
     
Exceptional Items0.00-424.6014.48-20.80
Profit/Loss Before Tax47.25-818.6352.258.43
     
Tax Expenses-Continued Operations    
Deferred Tax-15.400.000.000.00
Total Tax Expenses-15.400.000.000.00
Profit/Loss After Tax And Before ExtraOrdinary Items62.65-818.6352.258.43
     
Profit/Loss From Continuing Operations62.65-818.6352.258.43
     
Profit/Loss For The Period62.65-818.6352.258.43
     
OTHER INFORMATION    
     
EARNINGS PER SHARE    
Basic EPS (Rs.)3.70-48.523.100.50
Diluted EPS (Rs.)3.68-48.523.050.50